SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-040850
Filing Date
2020-03-31
Accepted
2020-03-31 08:25:42
Documents
14
Period of Report
2020-03-31
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2014246-1_8k.htm 8-K 24500
2 EXHIBIT 99.1 tm2014246d1_ex99-1.htm EX-99.1 24547
3 EXHIBIT 99.2 tm2014246d1_ex99-2.htm EX-99.2 14757
4 GRAPHIC image_001.jpg GRAPHIC 96253
5 GRAPHIC image_002.jpg GRAPHIC 150366
6 GRAPHIC image_003.jpg GRAPHIC 85684
7 GRAPHIC image_004.jpg GRAPHIC 66655
8 GRAPHIC image_006.jpg GRAPHIC 49062
9 GRAPHIC image_007.jpg GRAPHIC 51897
10 GRAPHIC image_008.jpg GRAPHIC 40148
11 GRAPHIC image_009.jpg GRAPHIC 51018
12 GRAPHIC image_010.jpg GRAPHIC 84599
13 GRAPHIC tm2014246d1_ex99-1img01.jpg GRAPHIC 2698
14 GRAPHIC image_0005.jpg GRAPHIC 66046
  Complete submission text file 0001104659-20-040850.txt   1091804
Mailing Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38944 | Film No.: 20759708
SIC: 2834 Pharmaceutical Preparations